Turn Therapeutics (TTRX) Operating Expenses (2024 - 2026)
Turn Therapeutics (TTRX) posted quarterly Operating Expenses of $1.2 million for Q1 2026, up 223.68% year-over-year from $384997.0 in Q1 2025, and down 43.19% quarter-over-quarter from $2.2 million in Q4 2025.
Turn Therapeutics (TTRX) Operating Expenses (2024 - 2026) Analysis & Trends
Turn Therapeutics' Operating Expenses history runs 3 years deep, the most recent figure standing at $1.2 million for Q1 2026.
- In Q1 2026, Operating Expenses rose 223.68% year-over-year to $1.2 million; the TTM figure through Mar 2026 stood at $5.7 million (changed N/A YoY), while the FY2025 annual figure was $5.9 million, up 226.0% from the prior year.
- Operating Expenses for Q1 2026 stood at $1.2 million, down from $2.2 million in the prior quarter.
- The five-year high for Operating Expenses was $2.2 million in Q4 2025, with the low at $328957.0 in Q4 2024.
- The 3-year median for Operating Expenses is $959567.5 (2024), against an average of $1.1 million.
- Peak annual rise in Operating Expenses reached 566.83% in 2025, while the deepest fall reached 184.34% in 2025.
- Turn Therapeutics' Operating Expenses stood at $328957.0 in 2024, then surged by 566.83% to $2.2 million in 2025, then plunged by 43.19% to $1.2 million in 2026.
- Business Quant data shows TTRX's Operating Expenses at $1.2 million in Q1 2026, $2.2 million in Q4 2025, and $1.9 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 2.09 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 3.00 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 2.89 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 505.13 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.21 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 4,978.15 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 541.02 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.06 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 427.03 Mn |
| 10 | Turn Therapeutics | 285.07 Mn | 285.07 Mn | - | 1.63 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.63 Mn |
| Mar 31, 2026 | 1.25 Mn |
| Dec 31, 2025 | 2.19 Mn |
| Sep 30, 2025 | 1.91 Mn |
| Mar 31, 2025 | 384,997.00 |
| Dec 31, 2024 | 328,957.00 |
| Sep 30, 2024 | 672,992.00 |